- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 41.11M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 41.11M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 41.11M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$77.78K |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$72.35K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $531.31K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $287.25K |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$2.84M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$2.5M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $7.99M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $5.73M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $8.05M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.8M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $5.77M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.3M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $8.58M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.08M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.01 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $62.19K |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $79.85K |
| Net Income | Q1 2026 · Mar 31, 2026 | $244.06K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$345.34K |
| Operating Income | Q1 2026 · Mar 31, 2026 | $223.16K |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$79.85K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $285.35K |
| Revenue | Q1 2026 · Mar 31, 2026 | $3.26M |